These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10722925)

  • 1. The experimental investigation of ultrasonic properties for a sonicated contrast agent and its application in biomedicine.
    Zhang D; Gong XF; Liu JH; Shao LZ; Li XR; Zhang QL
    Ultrasound Med Biol; 2000 Feb; 26(2):347-51. PubMed ID: 10722925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases.
    Porter TR; Xie F
    J Am Coll Cardiol; 1995 Feb; 25(2):509-15. PubMed ID: 7829807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonicated X-ray contrast agents for quantitative myocardial contrast echocardiography--a critical approach.
    Mayer IV; Lazarov MP; Utzinger U; Freiburghaus AU; Hess OM
    Heart Vessels; 1995; 10(2):96-105. PubMed ID: 7782270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism and clinical implication of improved left ventricular videointensity following intravenous injection of multi-fold dilutions of albumin with dextrose.
    Porter TR; Xie F; Kricsfeld A
    Int J Card Imaging; 1995 Jun; 11(2):117-25. PubMed ID: 7673759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of ultrasonic contrast agents using a dual-frequency band technique.
    Deng CX; Lizzi FL; Kalisz A; Rosado A; Silverman RH; Coleman DJ
    Ultrasound Med Biol; 2000 Jun; 26(5):819-31. PubMed ID: 10942829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental acoustic characterization of an endoskeletal antibubble contrast agent: First results.
    Panfilova A; Chen P; van Sloun RJG; Wijkstra H; Postema M; Poortinga AT; Mischi M
    Med Phys; 2021 Nov; 48(11):6765-6780. PubMed ID: 34580883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of acoustic nonlinearity parameter B/A in liquids containing ultrasound contrast agents.
    Xia L
    J Acoust Soc Am; 2019 Aug; 146(2):1394. PubMed ID: 31472549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric microballoons as ultrasound contrast agents. Physical and ultrasonic properties compared with sonicated albumin.
    Schneider M; Bussat P; Barrau MB; Arditi M; Yan F; Hybl E
    Invest Radiol; 1992 Feb; 27(2):134-9. PubMed ID: 1376304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion.
    Bleeker H; Shung K; Barnhart J
    J Ultrasound Med; 1990 Aug; 9(8):461-71. PubMed ID: 2204718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of acoustic droplet vaporization for control of bubble generation under flow conditions.
    Kang ST; Huang YL; Yeh CK
    Ultrasound Med Biol; 2014 Mar; 40(3):551-61. PubMed ID: 24433748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on the inertial cavitation threshold and shell properties of commercialized ultrasound contrast agent microbubbles.
    Guo X; Li Q; Zhang Z; Zhang D; Tu J
    J Acoust Soc Am; 2013 Aug; 134(2):1622-31. PubMed ID: 23927202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of echo-contrast effects.
    Powsner SM; Keller MW; Saniie J; Feinstein SB
    Am J Physiol Imaging; 1986; 1(3):124-8. PubMed ID: 3451757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative myocardial ultrasonic integrated backscatter measurements during contrast injections.
    Meltzer RS; Ohad DG; Reisner S; Sucher E; Kaplinsky E; Motro M; Battler A; Vered Z
    J Am Soc Echocardiogr; 1994; 7(1):1-8. PubMed ID: 8155327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifold sonicated dilutions of albumin with fifty percent dextrose improve left ventricular contrast videointensity after intravenous injection in human beings.
    Porter TR; Xie F; Anderson JR; Kricsfeld A; D'Sa A
    J Am Soc Echocardiogr; 1994; 7(5):465-71. PubMed ID: 7986543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ultrasound frame rate on perfluorocarbon-exposed sonicated dextrose albumin microbubble size and concentration when insonifying at different flow rates, transducer frequencies, and acoustic outputs.
    Porter TR; Kricsfeld D; Cheatham S; Li S
    J Am Soc Echocardiogr; 1997; 10(6):593-601. PubMed ID: 9282348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrasound contrast agents--physical basics].
    Kollmann C; Putzer M
    Radiologe; 2005 Jun; 45(6):503-12. PubMed ID: 15809841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental investigations of nonlinearities and destruction mechanisms of an experimental phospholipid-based ultrasound contrast agent.
    Casciaro S; Palmizio Errico R; Conversano F; Demitri C; Distante A
    Invest Radiol; 2007 Feb; 42(2):95-104. PubMed ID: 17220727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of an ultrasound-activated contrast microbubble with a wall at arbitrary separation distances.
    Doinikov AA; Bouakaz A
    Phys Med Biol; 2015 Oct; 60(20):7909-25. PubMed ID: 26407104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study on efficacy of myocardial opacification owing to difference of echocardiographic contrast agents].
    Suzuki M; Yamaguchi T
    Nihon Rinsho; 1998 Apr; 56(4):909-13. PubMed ID: 9577607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin.
    Porter TR; Xie F; Kricsfeld A; Chiou A; Dabestani A
    J Am Coll Cardiol; 1994 May; 23(6):1440-3. PubMed ID: 8176104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.